77 related articles for article (PubMed ID: 10914267)
1. [Breast cancer prevention in high risk individuals: the surgical aspects].
Papa MZ; Ayalon S; Mintz I; Ben-Ari G
Harefuah; 1999 Mar; 136(6):474-6. PubMed ID: 10914267
[No Abstract] [Full Text] [Related]
2. [A genetic test for breast cancer: curse or blessing?].
Sauer H
Fortschr Med; 1995 Feb; 113(4):9-10. PubMed ID: 7713472
[No Abstract] [Full Text] [Related]
3. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
Hamann U
Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
[TBL] [Abstract][Full Text] [Related]
4. [Under what conditions should we propose a prophylactic mastectomy for a woman at risk?].
Gauthier-Villars M; Blandy C; Stoppa-Lyonnet D
Bull Cancer; 1999 Sep; 86(9):754-9. PubMed ID: 10576812
[No Abstract] [Full Text] [Related]
5. Hereditary breast cancer.
Robson ME; Boyd J; Borgen PI; Cody HS
Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
[No Abstract] [Full Text] [Related]
6. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition testing for breast cancer.
Audeh MW
Cancer J Sci Am; 1997; 3(4):254-5. PubMed ID: 9263632
[No Abstract] [Full Text] [Related]
8. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
[TBL] [Abstract][Full Text] [Related]
9. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
Ost E; Illiger HJ
Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
[No Abstract] [Full Text] [Related]
10. Breast cancer genetics: what we know and what we need.
Nathanson KL; Wooster R; Weber BL
Nat Med; 2001 May; 7(5):552-6. PubMed ID: 11329055
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
Rebbeck TR
J Clin Oncol; 2000 Nov; 18(21 Suppl):100S-3S. PubMed ID: 11060335
[TBL] [Abstract][Full Text] [Related]
12. BRCA: the breast, ovarian, and other cancer genes.
Boyd J
Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927
[No Abstract] [Full Text] [Related]
13. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
14. BRCA2 mutation in a family with hereditary prostate cancer.
Grönberg H; Ahman AK; Emanuelsson M; Bergh A; Damber JE; Borg A
Genes Chromosomes Cancer; 2001 Mar; 30(3):299-301. PubMed ID: 11170288
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention options for BRCA1 and BRCA2 mutation carriers.
Eeles RA; Powles TJ
J Clin Oncol; 2000 Nov; 18(21 Suppl):93S-9S. PubMed ID: 11060334
[TBL] [Abstract][Full Text] [Related]
16. Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?
Kurtz JM
Strahlenther Onkol; 2000 Sep; 176(9):433-4. PubMed ID: 11050918
[No Abstract] [Full Text] [Related]
17. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
18. [From gene to disease; from BRCA1 OR BRCA2 to breast cancer].
Van den Ouweland AM
Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1228. PubMed ID: 11447881
[No Abstract] [Full Text] [Related]
19. Should you be taking tamoxifen?
Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691
[No Abstract] [Full Text] [Related]
20. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
Healey CS; Dunning AM; Teare MD; Chase D; Parker L; Burn J; Chang-Claude J; Mannermaa A; Kataja V; Huntsman DG; Pharoah PD; Luben RN; Easton DF; Ponder BA
Nat Genet; 2000 Nov; 26(3):362-4. PubMed ID: 11062481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
